- Telehealth Visits
- Insurance plan information
- Provider Type: Nurse Practitioner
Jordyn Blackburn, NP
- Telehealth Visits
- Insurance plan information
- Provider Type: Nurse Practitioner
Jordyn Blackburn, NP
- Telehealth Visits
- Insurance plan information
- Provider Type: Nurse Practitioner
On this page
About me
Jordyn Blackburn is a nurse practitioner who cares for hospitalized patients with advanced heart failure. She evaluates them to determine which advanced treatments are appropriate. Her expertise includes prostacyclin therapy (medications to lower high blood pressure in the lungs), heart transplantation treatments (both before and after the procedure), cardiac resynchronization therapy (using a pacemaker to restore normal heart rhythm) and medication optimization (assessing the patient's response to drugs currently in use and finding opportunities for improvement).
Blackburn earned her bachelor's degree in nursing as well as her master's degree in nursing at Grand Canyon University, where she focused on acute care and the care of patients in all stages of adulthood. Before becoming a nurse practitioner, she worked as a cardiac critical care nurse for 12 years.
Education & training
Board certification
- Adult Gerontology Acute Care Nurse Practitioner, American Nurses Credentialing Center
Degree
- MSN, Grand Canyon University
My expertise
Conditions
Clinical Trials query: q=health_gateway_id_ss%3A%28%225538%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=start_date_dt+asc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%225538%22%29&rows=4&sort=date_published+asc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.